|
1. Shadzi Sh. Pathogenic yeasts. In: Medical Mycology. Isfahan University: Jihad Press; 2007. ]in Persian [ 2. Lopes Consolaro ME, Aline Albertoni T, Shizue Yoshida C, Mazucheli J, Peralta RM, Estivalet Svidzinski TI. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringa, Parana, Brazil. Rev Iberoam Micol 2004; 21: 202-5. 3. Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, et al. Patten of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J Infect 2006; 52(2): 111-7. 4. Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol Reprod Biol 2006; 126(1): 121-5. 5. Esmaeilzadeh S, Mahdavi Omran S, Rahmani Z. Frequency and etiology of vulvovaginal candidiasis in women referred to a gynecological center in Babol, lran. Int J Fertil Steril 2009; 3(2): 74-7. 6. Kendirci M, Koç AN, Kurtoglu S, Keskin M, Kuyucu T. Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004; 17(11): 1545-9. 7. McCormack W. Vulvovaginitis and cervicitis. In: Mandell. Douglas and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Churchil Livigstone; 2010. p. 1495-509. 8. Fidel PL Jr. History and new insights into host defense against vaginal candidiasis. Trends Microbiol 2004; 12(5): 220-7. 9. Kariman N, Shafai Z, Afrakhte M, Valai N, Ahmadi M. Comparative study of traputic effects of fluconazole and clotrimazole on candida vaginitis. J Behbood 2002; 6(13): 9-16. 10. Martinez RCR, Franceschini SA, Patta MC, Quintana SM, Candido RC, Frreira ECP, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic lactobacillus rhamnosus GR-1 and lactobacillus reuteri RC-14. Lett Appl Microbiol 2009; 48(3): 269-74. 11. Berek JS. Berek & Novak’s Gynecology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2007 .p. 542-7. 12. Habibian R, Jafarzadeh L, Shahriari K. Investigating the relationship between recurrent candidiasis with predisposing factors and symptoms of disease. J Shahrekord Univ Med Sci 2013; 15 (5): 38-46. ]in Persian [ 13. Aghamirian MR, Keshavarz D, Jahani Hashemi H, Sadeghi Qazvini M. Agents associated with candida vulvovaginitis in women referred to health centers in Qazvin. J Qazvin Univ Med Sci 2007; 11(3): 35-9. ]in Persian [ 14. Nazeri M, Mesdaghinia E, Moraveji AR, Atabakhshiyan R, Soleymani F. Prevalence of Vulvovaginal Candidiasis and Frequency of Candida Species in Women. J Mazand Univ Med Sci 2012; 22(86): 255-62. ]in Persian [ 15. Akbarzdeh M, Bonyadpoure B, Pakshir K, Mohagheghzadeh A. Causes and clinical symptoms of vaginal candidiasis in patients referring to selective clinics of Shiraz University of Medical Sciences (2009). Arak Med Univ J 2010; 13(3): 12-20. ]in Persian [ 16. Bayani M, Asghar Sefidgar SA, Basirat Z, Haji Ahmadi M, Asgharzadeh S, et al. Association of clinical symptoms and laboratory results in diagnoses of candida vaginitis. J Babol Univ Med Sci 2014; 16(1): 50-5. ]in Persian [ 17. Panahi F, Kordbacheh P, Rezaie S, Zeini F, Zeraati H, Safara M. Determination of candida species in acute and recurrent candida vulvovaginitis. J Microbiol Knowledge 2009; 1(3): 7-12. ]in Persian [ 18. Sobel JD. Vulvovaginitis. When Candida becomes a problem. Dermatol Clin 1998; 16: 763-8. 19. Nyirjesy P, Seeney SM, Grody MH, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 1995; 173 (3 Pt 1): 820-3. 20. Ramezani Tehrani F, Farahmand M, Abedini M, Hashemi Z. Prevalence of vaginitis in Iranian women - symptoms and clinical association. Med Sci J Islamic Azad Univ 2012; 22(1): 62-8. ]in Persian [ 21. Omar AA. Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. East Mediterr Health J 2001; 7(6): 925-34. 22. Linhares IM, Witkin SS, Miranda SD, Fonseca AM, Pinotti JA, Ledger WJ. Differentiation between women with vulvovaginal symptoms who are positive or negative for candida species by culture. Infect Dis Obstet Gynecol 2001; 9(4): 221-5. 23. Chassot F, Negri MF, Svidzinski AE, Donatti L, Peralta RM, Svidzinski TI, et al. Can intrauterine contraceptive devices be a Candida albicans reservoir? Contraception 2008; 77(5): 355-9. 24. Karaer A, Boylu M, Avsar AF. Vaginitis in Turkish women: symptoms, epidemiologic microbiologic association. Eur J Obstet Gynecol Reprod Biol 2005; 121(2): 211-5. 25. Eschenbach DA. Pelvic and sexually transmitted infections. In: Ronald SG, Beth YK, Arthur FH, Ingrid N. Danforths obstetrics and genecology. Philadelphia: Williams and Wilkins; 2008. p. 609. 26. Khoursandi M, Modares Gilani M, Khosravi AR. Treatment and recurrence of vaginal candidiasis after oral and intravaginal treatment. J Qazvin Univ Med Sci 2000; 4(2): 25-9. ]in Persian[ 27. Jamilian M, Mashhadi E, Sarmadi F, Ghaznavirad A, Bani Jamali MAS, Farhadi E, et al. Frequancy of vulvovaginal candidiasis species in nonpregnant 15-50 years old women in spring 2005 in Arak. J Arak Univ Med Sci (Rahavard-E Danesh) 2007; 10(2(39)): 7-14. ]in Persian [ 28. Paulitsch A, Wager W, Grinter–Hanselmayer G, Marrth E, Buzina W. A 5s-year (2000-2004) epidemlological survey of Candida vulvovaginal candidiasis in Graz, Austria. Mycoses 2006; 49(6): 471-5. 29. Moreira D, Paula CR. Vulvovaginal candidiasis. Int J Gynecol Obstet 2006; 92(3): 266-7.
|
.png){kind=logo}
